Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Sanofi Winthrop discloses topoisomerase II inhibitors

Aug. 16, 1996

Guilford to develop anticancer drugs in biodegradable polymers

Aug. 16, 1996

SuperGen acquires marketing rights for Barr generic drugs

Aug. 16, 1996

SS Pharm. discloses antitumor platinum complexes

Aug. 16, 1996

NCI supports clinical testing of MGI-114

Aug. 16, 1996

NCI begins pediatric study of carboplatin/RMP-7 combination

Aug. 16, 1996

FDA approves new formulation of Gensi Laboratories' etoposide

Aug. 9, 1996

Water-soluble prodrug of pancratistatin synthesized by Arizona State University

Aug. 9, 1996

Mylan to market generic Taxol in 3 countries

Aug. 9, 1996

RPR seeks approval of Campto in 13 European countries

Aug. 9, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 9, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
Brenig Therapeutics discovers new LRRK2 inhibitors
BioWorld Science
Brenig Therapeutics Inc. has described leucine-rich repeat kinase 2 (LRRK2; dardarin) and (LRRK2; dardarin) (G2019S mutant) inhibitors reported to be useful for...